Proof of Concept Study on Pitolisant Effect on Autism Spectrum Disorders in Children and Adolescents
- Conditions
- Autism Spectrum Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-07-20
- Last Posted Date
- 2023-07-20
- Lead Sponsor
- Bioprojet
- Target Recruit Count
- 62
- Registration Number
- NCT05953389
- Locations
- 🇫🇷
Centre Hospitalier Charles Perrens, Bordeaux, France
🇫🇷Nantes University Hospital, Nantes, France
🇫🇷CH le Rouvray, Sotteville-lès-Rouen, France
Proof of Concept Study Evaluating BP1.3656 in Patients With Fatigue Following Ischemic Stroke
- Conditions
- Fatigue
- Interventions
- Drug: BP1.3656
- First Posted Date
- 2022-02-15
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Bioprojet
- Target Recruit Count
- 5
- Registration Number
- NCT05240560
- Locations
- 🇨ðŸ‡
Inselspital Berne, Berne, Switzerland
🇫🇷Hôpital Pellegrin - CHU BORDEAUX, Bordeaux, France
Pilot Study on BP1.4979 Effect on Binge Eating Disorders
- Conditions
- Binge-Eating Disorder
- Interventions
- Drug: BP1.4979 active drugDrug: Placebo
- First Posted Date
- 2021-11-12
- Last Posted Date
- 2024-04-15
- Lead Sponsor
- Bioprojet
- Target Recruit Count
- 66
- Registration Number
- NCT05118906
- Locations
- 🇫🇷
Nutrition Department, La Pitié Salpêtrière Hospital, Paris, France
Randomized Clinical Trial Evaluating BP1.3656 Versus Placebo For Alcohol Use Disorder Treatment
- Conditions
- Alcohol Use Disorder
- Interventions
- Drug: BP1.3656 low doseDrug: BP1.3656 intermediate doseDrug: PlaceboDrug: BP1.3656 high dose
- First Posted Date
- 2018-02-07
- Last Posted Date
- 2022-01-21
- Lead Sponsor
- Bioprojet
- Target Recruit Count
- 210
- Registration Number
- NCT03424824
- Locations
- 🇧🇬
State Psychiatric Hospital for Treatment of Drug Addiction and Alcoholism, Sofia, Bulgaria
🇫🇷CHU Amiens Picardie, Amiens, France
🇷🇺Leningrad Regional Narcology Dispensary, Leningrad, Russian Federation
Clinical Trial Assessing the Efficacy and Safety of BP1.4979 in Restless Legs Syndrome
- First Posted Date
- 2017-11-17
- Last Posted Date
- 2020-07-30
- Lead Sponsor
- Bioprojet
- Target Recruit Count
- 29
- Registration Number
- NCT03345953
- Locations
- 🇫🇷
Clinical Neurophysiology Department - Hôpital Pellegrin, Bordeaux, France
Determination the Abuse Potential of Pitolisant in Healthy, Non-Dependent Recreational Stimulant Users
- Conditions
- HealthyDrug Abuse
- Interventions
- First Posted Date
- 2017-05-12
- Last Posted Date
- 2017-11-13
- Lead Sponsor
- Bioprojet
- Target Recruit Count
- 43
- Registration Number
- NCT03152123
- Locations
- 🇨🇦
INC Research, Toronto, Ontario, Canada
Pitolisant (BF2.649) in the Treatment of Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnoea Syndrome, Treated or Not by Nasal Continuous Positive Airway Pressure, But Still Complaining of Excessive Daytime Sleepiness
- Conditions
- Excessive Daytime SleepinessObstructive Sleep Apnea
- Interventions
- Drug: Placebo Oral Tablet
- First Posted Date
- 2016-12-01
- Last Posted Date
- 2017-11-24
- Lead Sponsor
- Bioprojet
- Registration Number
- NCT02978651
- Locations
- 🇫🇷
Hôpital Gui de Chauliac, CHU Montpellier, Unité des Troubles du Sommeil et de l'Eveil, Montpellier, France
🇫🇷Laboratoire du sommeil Clinique de Physiologie, Sommeil et Exercice Pôle Thorax et Vaisseaux CHU de Grenoble, Grenoble, France
Study to Assess the Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]-Pitolisant in Healthy Male Volunteers
- Conditions
- Healthy Volunteers
- Interventions
- Radiation: [14C]-Pitolisant
- First Posted Date
- 2016-10-11
- Last Posted Date
- 2016-10-11
- Lead Sponsor
- Bioprojet
- Target Recruit Count
- 8
- Registration Number
- NCT02929342
A Trial Evaluating Pitolisant (BF2.649) in Alcohol Use Disorder Treatment
- Conditions
- Alcohol Abuse, Nervous System
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-06-15
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- Bioprojet
- Registration Number
- NCT02800083
Pitolisant (BF2.649) in the Treatment of EDS in Patients With OSA
- Conditions
- Excessive Daytime SleepinessObstructive Sleep Apnea
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-04-15
- Last Posted Date
- 2020-07-08
- Lead Sponsor
- Bioprojet
- Target Recruit Count
- 389
- Registration Number
- NCT02739568
- Locations
- 🇧🇬
University Multiprofile Hospital for Active Treatment "Aleksandrovska" EAD, Sofia, Bulgaria
🇧🇬Specialised Hospital for Active Treatment of pneumo-phthisiatric diseases - Burgas" EOOD, Pneumology ward, Burgas, Bulgaria
🇧🇬Multiprofile Hospital for Active Treatment "Sv. Ivan Rilski" EOOD, Kozloduy, Bulgaria